Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    No substantive changes to the study details were observed between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:27.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Core update: add a government funding status notice and update to v3.2.0; remove the old v3.1.0 tag. The new notice provides critical operational status, making it the primary change.
    Difference
    3%
    Check dated 2025-10-05T10:16:30.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updated version to v3.1.0 with new contact details (emails and phone numbers) and removal of the old version v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-28T03:20:01.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, indicating a minor update from v3.0.1. The 'Back to Top' navigation element has been removed, a minor navigation change.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:41.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:21:48.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and various types of proteins and antibodies, while removing several specific terms related to locations and certain medical agents.
    Difference
    3%
    Check dated 2025-08-30T12:02:14.000Z thumbnail image

Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.